These include other FDA-approved weight management medications such as phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), or orlistat (Xenical, Alli), though these agents generally produce less weight loss than GLP-1 medications
25 Cherbut C, Michel C, Raison V, Kravtchenko TP, Meance S
-Catenin/POU5F1/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinoma
Serotonergic drugs when taken with ALC might increase serotonin causing serious side effects such as heart problems, seizures, and vomiting
The test reveals predispositions in peptide signaling pathways (GIPR rs1800437, FTO rs9939609, MC4R rs17782313) and nutrient-metabolism markers that may influence how you tolerate GLP-1 therapy and absorb nutrients from supplements like moringa